NCT07589608 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight Status NOT_YET_RECRUITING Phase PHASE2
NCT07392190 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin Status RECRUITING Phase PHASE3
NCT07369011 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight Status RECRUITING Phase PHASE3
NCT07353931 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight Status RECRUITING Phase PHASE3
NCT07321886 A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes Status RECRUITING Phase PHASE3
NCT07282600 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes Status RECRUITING Phase PHASE3
NCT07215559 A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes Status RECRUITING Phase PHASE2
NCT06916091 A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight Status COMPLETED Phase PHASE1
NCT06916065 A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity Status COMPLETED Phase PHASE1